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Postmenopausal Osteoporosis: The evolution 
of our concepts of its cause* 
Harold M. Frost, M.D.** 
Research findings in the last 20 years concerning senile and postmenopausal 
osteoporosis indicate that the skeletal condition associated with these diseases 
arises because some systemic factor acts directly upon the bone marrow tissues. 
There is a secondary tendency to accelerate loss of bone greater than in the 
normal aging process. The loss occurs only on those surfaces in physical con-
tact with the bone marrow tissue. 
This article summarizes changes 
during the past decade in our thinking 
about the pathophysiology of post-
menopausal osteoporosis which justify 
this rather bold and possibly even novel 
conclusion: 
Postmenopausal osteoporosis 
emerges as an effect oj an underlying 
bone marrow tissue disorder. 
To set the stage for this idea we 
should review briefly some concepts of 
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bone physiology and osteoporosis 
which enjoyed some vogue about 30 
years ago. We can then appreciate best 
the significance of more recent devel-
opments. 
The Assumptions 
Approximately 30 years ago Fifller 
Albright's pioneer writings reflected 
the known facts that bone was a living 
tissue, one resorbed by osteoclasts and 
made by osteoblasts.^  It seemed logical 
then that, in the operational sense, 
osteoblasts throughout the skeleton 
probably represented one single collec-
tion of cefls in the functional sense and 
osteoclasts another (hence the "singu-
larity" assumption). Furthermore, they 
were assumed to function essentially 
independently of each other in re-
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sponding to systemic regulation by 
blood-borne messengers of chemical or 
hormonal nature (hence, the "inde-
pendence" assumption). Further, and 
of particular importance here, it was 
assumed that this systemic regulation 
acted either to directly depress osteo-
blasts (Albright's view), or to directly 
stimulate osteoclasts (a view I favored 
for a time, in the good company of 
many others), leading thereby to the 
deficient amount of bone tissue known 
to characterize the osteoporotic skele-
ton. Unfortunately, so far, attempts to 
find a medication which would selec-
tively either stimulate the body's osteo-
blasts, or inhibit its osteoclasts have 
been unsuccessful. 
Why? I suggest that the problem 
may be a consequence of the way we 
were taught to think of the pathophy-
siology of the osteoporoses. Here is 
some evidence supporting this con-
tention: 
1) The "Independence" Assumption 
While bone loss of great magnitude 
may occur in some adult systemic 
diseases, it usually proceeds only to a 
certain point, so that the amount of 
bony tissue remaining in the skeleton 
tends to plateau. This implies some 
connection between the capacities to 
resorb and to form bone. (Here we 
ignore localized processes, such as 
bone tumors and infections.) 
In that connection, histological stud-
ies at Henry Ford Hospital eventually 
demonstrated a real connection be-
tween osteoclastic and osteoblastic 
activity in both human and animal 
material. Specifically, lamellar bone 
turnover in adult humans occurs in 
functionafly as well as histologically 
distinguishable "packets" or remodel-
ing units, which we have cafled Basic 
Multicellular Units, (BMU).^ These 
units bear several close analogies to 
the nephrons in the kidney. With 
great regularity, a typical bone re-
modeling BMU begins as a center of 
bone resorption, characterized by ac-
tive osteoclastic removal of a moiety 
of bone amounting to approximately 
.05mm'5 within less than a month. 
Osteoclastic activity then subsides, new 
osteoblasts materialize during the fol-
lowing days and proceed to fill in the 
eroded cavity during the next three 
months or so with a nearly equal 
amount of newly-made bone.^  
That sequence characterizes adult 
lamellar bone remodeling in man as 
well as in many other medium and 
large-sized mammals (such as dogs, 
goats, cats, monkeys, whales, rabbits, 
sheep, horses, and cows). Also, it oc-
curs on all of the periosteal, haversian, 
cortical-endosteal and trabecular sur-
faces. Its twin properties of temporal 
sequence and spatial discreteness per-
sist alike in health and in a wide variety 
of skeletal diseases. Within cortical 
bone, the remodeling sites (termed 
secondary osteons or haversian sys-
tems) resemble tubes some 150 to 250 
microns in diameter "drilled" or ori-
ented parallel to the longitudinal axis 
of the bone. On endosteal surfaces 
(both cortical and trabecular), the bone 
remodeling centers have a semicircular, 
shingle-like configuration. In skeletally 
immature animals this simple morpho-
logical picture becomes mixed with 
quite different forms of bone resorbing 
and formative activities, ie, forms 
peculiar to skeletal growth, which effec-
tively overshadowed the remodeling 
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patterns from earlier morphologists and 
physiologists. 
In other words, in normal adult 
bone remodeling one finds that bone 
resorption and bone formation do not 
occur as independent cellular activities. 
This neatly explains why experimental 
manipulations which after resorption in 
intact animals also alter formation in 
the same direction. This occurs ajter a 
predictable titne lag needed for the 
typical BMU to progress through its 
resorption phase into its formation 
phase (sigma-). Naturafly this coupling 
wifl only be detected if an experiment 
continues long enough for the "switch-
over" to occur, the necessary time vary-
ing from about two months in a healthy 
rabbit to wefl beyond 10 years in some 
cases of human osteomalacia. The cel-
lular mechanisms that "couple" resorp-
tion to formation in the manner de-
scribed remain unknown. 
The BMU concept as well as the 
BMU structure, in both the temporal 
and morphological senses, suggest sev-
eral possible ways in which the balance 
between bone resorption and formation 
within one BMU can change so as 
to accelerate bone loss. Our own group 
and others'^ -^  have shown that in the 
average BMU the balance between 
the amount of bone removed by the 
resorptive process and that replaced 
by the following formation process 
changes in a characteristic way as one 
crosses the thickness of the cortex 
from the periosteal to the endosteal 
bone surfaces. An excess of formation 
on the periosteal surface becomes a 
negligible excess of resorption on ha-
versian surface, which increases as 
one moves toward the marrow cavity, 
there to become a relatively large ex-
cess. We can summarize these simple 
but important matters thus: 
(i) In normal periosteal remodeling 
BMU, slightly more bone is 
replaced than is removed. 
(ii) In normal haversian BMU, 
slightly less bone is replaced 
than is removed. 
(iii) In normal cortical-endosteal 
BMU, considerably less bone is 
replaced than is removed. 
In 1967 Wu, Jett and the author 
estimated, on the basis of quantitative 
histological measurements, that the 
resorptive excess per endosteal BMU 
in both normal and osteoporotic pa-
tients exceeds by approximately 70 
times the resorptive excess found per 
haversian BMU." (See Figure 1) A 
65 yr. 
Figure 1 
Resorption relative to formation per 
normal BMU on haversian and cortical-en-
dosteal surfaces, expressed as relative 
amounts of bone resorbed and made. Any 
difference in their amount would tend to 
make bone accumulate (in the case of an 
excess of formation), or decrease (in the 
case of a resorptive excess). This probably 
accounts for expansion of the marrow cav-
ity during adult life in man. 
83 
Frost 
relatively small further increase in the 
magnitude of that excess could easfly 
account for the actual losses of cortical 
and trabecular bone observed in pa-
tients with osteoporosis. Beginning in 
early adult life, an increase in the size 
of each "bite" taken out of the skeleton 
by the average endosteal BMU and 
added up over a period of some 20 
to 50 years could explain those losses. 
Observe here the useful facts that, 
whfle spongy bone represents only 
about 20% of the total bone mass*, 
it supplies more than 70% of the 
total skeletal surface. Partly for that 
reason any factor which increased the 
net excess of bone resorption per endo-
steal BMU would subsequently reduce 
the amount of trabecular bone faster 
than it thinned the cortex. 
The "independence" assumption, I 
believe, proves partially false as it 
applied to adult bone remodeling. 
Osteoclasts and osteoblasts are some-
how tethered to each other in the func-
tional sense and by the BMU structure. 
2) The "Singularity" Assumption 
In the process of developing quanti-
tative histological techniques fof ana-
lyzing bone dynamics around 1960, we 
began to (a) use three anatomically 
distinguishable types of skeletal bony 
surfaces (ie, the periosteal, haversian, 
and cortical-endosteal surfaces), (b) 
define "envelopes" of bone tissue 
space, and (c) indicate in those terms 
the quantity of bone tissue in standard 
diaphyseal bone cross sections. Thus, 
the periosteal surfaces of the skeleton 
periosteal envelope do indeed envelop 
a definite and easfly measured volume 
of bone and space. Simflarly, the haver-
sian canal surfaces (or haversian en-
velope) envelop a measurable volume 
of space and, finally, the endosteal en-
velope encompasses the marrow cavity 
volume. Note that the volume encom-
passed by any of these three surfaces 
in any person represents the arithmetic 
sum of all previous bone resorption 
and bone formation on that particular 
surface. (Figure 2) 
PERIOSTEAL 
HAVERSIAN 
TRABECULAR 
ENDOSTEAL 
CORTICAL 
ENDOSTEAL 
Figure 2 
A rib section indicating the anatomical 
location and meaning of the endosteal 
surface, periosteal surface, and haversian 
surface. 
This "envelope concept" led quite 
naturally to studies of changes in en-
velope cross-sectional sizes in standard 
biopsy sites during growth, adult life, 
aging and in a variety of congenital 
and metabolic bone diseases including 
the osteoporoses. In human rib sec-
tions, transverse expansions of both 
marrow cavity and outside diameter 
continue throughout life," although 
longitudinal growth of bone ceases at 
skeletal maturity. Initially controver-
sial, that observation has been con-
firmed by many others ^ ^ lO'ii'i^. It 
has been found also in human femur, 
vertebra, metacarpal, clavicle, skull, 
and entire skeletons, the only major 
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exception being the radial diaphysis.^ ^ 
Figure 3 shows that the amount of 
compacta uicreases during the growth 
period because the rate of periosteal 
expansion exceeds that of the marrow 
cavity. Once skeletal maturity arrives, 
the process reverses and the amount of 
compacta begins gradually to decrease 
because the marrow cavity expands 
faster than the periosteal envelope. 
During all that time, the intracortical 
porosity or haversian space changes 
little in relative size. Hence arises the 
normal age-related thinning of the 
RESORPTION 
F O R M A T I O N 
H A V E R S I A N C ORT I C A L 
E N D O S T E A L 
N : 70 
R E S O R P T I O N R E L A T I V E TO F O R M A T I O N 
p e r ' p a c k a g e ' n o r m a l s . 
Figure 3 
Diagrammatic representation of the nor-
mal age-related changes in "envelope" sizes 
in standard cross sections of the mid femur. 
(Reprinted with permission of Howard 
Duncan, M.D., and Z. F. Jaworski, M.D. 
and the publishers, Tice's Practice of Medi-
cine, Volume V, Chapter 52. 
compacta, termed by some the "phy-
siologic" osteoporosis of aging and, in 
the clinical sense, not really a disease 
that requires treatment. Note that 
trabeculae, surrounded entirely by the 
marrow cavity, display the same age-
related loss. That loss, however, is 
more pronounced because an expand-
ing marrow cavity erodes only the 
inner wall of the cortex surrounding 
it. It is, at the same time, eroding all 
four sides of a trabeculum. 
Thus, the "singularity" assumption 
did not apply to at least three opera-
tionally distinct collections of osteo-
clasts and the osteoblasts present on the 
three envelopes of a normal skeleton. 
The Envelope Matrix 
Since the three skeletal envelopes 
gain and lose bone independently dur-
ing growth, adult life, aging, and in 
a variety of diseases, we can depict 
skeletal mass problems as morphologi-
cal entities in terms of the respective 
sizes of each of these envelopes.-
Ignoring the haversian envelope for 
the present, one could construct a 
matrix of all possible combinations 
of periosteal and endosteal envelope 
sizes in simple terms of size-states, 
such as Increased, Normal, or De-
creased. Figure 4 illustrates such a 
matrix, portrays and lists examples of 
five possible types of osteoporoses, ie, 
envelope states which would represent 
less bony tissue in the skeleton than 
normal. 
Where does postmenopausal osteo-
porosis (PMO) fit into such a scheme? 
When examined from the morphologi-
cal standpoint the bones from afflicted 
patients reveal only enlargement of 
the endosteal envelope, and no other 
envelope size abnormality. (Square 2, 
87 
Frost 
Periosteal 
Envelope 
Endosteal 
Envelope N 
D 
N D 
©, ^" " ^ 2 3 
6 
Mii5>^ 8 9 
Figure 4 
Classification of possible combinations of the cross-sectional sizes of the periosteal and 
endosteal envelopes, assuming arbitrarily that each can take only one of three states or 
values-Increased, Normal or Decreased. The combination in square 5 is normal. The 
combinations in squares 1, 2, 3, 6, and 9 represent various kinds of osteoporoses. Squares 
4, 7 and 8 represent situations with too much bone. (Reprinted by permission: H. M. Frost, 
Bone Dynamics in Osteoporosis and Osteomalacia, Charles C. Thomas, Springfield, 
U.S.A. 1966). 
Figure 4) In other words, patients with 
PMO and also those wflh several other 
varieties of osteoporosis have lost only 
that bone in physical contact with 
the bone marrow. This fact implies 
that accelerated marrow cavity expan-
sion occurred during adult life, and 
secondly, that whatever changes in 
systemic "messengers" distributed by 
the blood might ultimately prove to 
cause this form of osteoporosis,"^-''' 
16,17 ^ j^ gy (Jo not act directly on osteo-
clasts and osteoblasts. Rather, they 
may well act on the soft tissues in the 
marrow cavity. After all, in the absence 
of any such anatomically localized 
intermediary, any blood-borne messen-
gers acting directly on bone cells in 
such a way as to enhance bone loss 
should cause such loss on all bony 
surfaces; yet, in postmenopausal osteo-
porosis that does not happen. Con-
sequently I have proposed'^  that the 
bone marrow which is altered by these 
systemic factors in some way affects 
the bone cells on the endosteal enve-
lope, causing the marrow cavity expan-
sion. 
Conclusion 
The specific marrow tissue pheno-
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] 
mena which might cause the endosteal 
bone loss in PMO seems to correlate 
best with some aspect of bone marrow 
activity. Several known associations 
suggest this: 
1. Hematopoietic activity in spongy 
bone exceeds that in cortical 
bone. So does osteoporosis. 
2. During menstrual years women 
have greater hematopoietic ac-
tivity than men. They also exhibit 
more osteoporosis. 
3. Some have suggested that hepar-
in might produce osteoporosis. 
At Henry Ford Hospital, Drs. 
Boy Frame and Robert Nixon 
have shown that increased 
numbers of mast cells, a source 
of heparin, occur in the mar-
row of patients with osteoporo-
sis. ' 
4. Osteoporosis in bones with red, 
hematopoietic marrow usually 
exceeds that in bones with fatty, 
yellow marrow. This may explain 
why it is more severe in the axial 
skeleton (red marrow) than in 
the appendicular (yellow mar-
row). 
It is reasonable to conclude that 
postmenopausal osteoporosis is a mar-
row tissue disorder which secondarily 
affects endosteal bone. Therefore, 
future investigations of the systemic 
factors which govern its characteristic 
bone loss should concentrate on the 
bone marrow and, particularly, on its 
interactions with endosteal bone. 
The following comments may help 
keep these ideas in perspective: 
(1) For reasons of space, we have 
not mentioned here some additional, 
characteristic, and consistently present 
abnormal dynamic features which oc-
cur in the bony skeleton in postmeno-
pausal and senfle osteoporoses. 
(2) Only a small fraction of all 
postmenopausal women who display 
radiographic evidence of subnormal 
bone density also have the clinical 
disease of osteoporosis (consisting of 
clinical disabflity due to spontaneous 
structural failure). Our remarks here 
apply only to osteoporosis, the disease, 
which may ultimately prove to be no 
more than an acceleration and aug-
mentation of otherwise perfectly nor-
mal age-dependent skeletal trends. 
(3) The association between the 
menopause and this disease may prove 
somewhat incidental, as it fundamen-
tally resembles the "senile" osteoporo-
sis seen in both women and men. 
(4) At this time,- I suspect that 
neither mast cells nor heparin directly 
cause the osteoporosis under discussion 
and that increased mast cefls in PMO 
probably represent a more basic under-
lying abnormality in the bone marrow 
which accounts for both phenomena. 
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